Principal
Investigators
|
|
Peter Brooks , Ph.D.
contact: brookp1@mmc.org
go to biographical profile
|
|
Robert
Friesel, Ph.D. (Director)
contact: friesr@mmc.org
go to biographical profile
- Normal
and abnormal signal transduction during bone growth and
development
- Identification
of novel antagonists of FGF signaling
|
|
Lucy
Liaw, Ph.D.
contact: liawl@mmc.org
go to biographical profile
- Murine
transgenic approaches to study vascular remodeling
- Tumor
growth and blood vessel recruitment
|
|
Volkhard
Lindner, M.D., Ph.D.
contact: lindnv@mmc.org
go to biographical profile
- The
biology of high molecular weight FGF-2 complexes
- Characterization
of novel genes expressed in the vessel wall
|
|
Leif
Oxburgh, DVM, PhD
contact: oxburl@mmc.org
go to biographical profile
- Identification
and characterization of the undifferentiated precursor cells
that give rise to the nephron within the developing kidney
- Signals
and genetic programs regulating the differentiation of nephron
precursor
|
|
Ilka
Pinz ,
Ph.D.
contact: pinzi@mmc.org
go to biographical profile
- Mechanisms
leading to the development of cardiomyopathy in dyslipidemia
|
|
Igor
Prudovsky , Ph.D.
contact: prudoi@mmc.org
go to biographical profile
- The
Role of FGF and Jagged in the regulation of angiogenesis
- Novel
mechanisms of protein trafficking
|
|
Douglas
Spicer, Ph.D.
contact: spiced@mmc.org
go to biographical profile
- Regulation
of growth and differentiation of muscle, bone, and endothelial
cells
- Transcriptional
regulation of mesenchyme formation from the cranial neural
crest
|
|
Calvin
Vary, Ph.D.
contact: varyc@mmc.org
go to biographical profile
- Mechanisms
of heretible vascular disease; roles of endoglin and ALK1
in the vasculature
- TGF-beta
receptor signaling mechanisms in vascular and bone physiology
|
|
Joseph
Verdi, Ph.D.
contact: verdij@mmc.org
go to biographical profile
- Determining
the molecular mechanisms underlying self renewal and lineage
specification of multipotential stem cellsExamining the clonal
transdifferentiaiton of neural precursors into hematpoietic
and myogenic lineagesStudying the ontogeny of NKT cells a s
a potential cure for type I diabetes
- Evaluating
stem cell cellular transplantation to abrogate seizure activity
in development
|
|
Zack
Wang, Ph.D.
contact: wangz@mmc.org
go to biographical profile
- Hematopoietic
and endothelial differentiation of embryonic stem (ES) cells
- The
molecular mechanisms that control fate determination of vasculogenesis
and hematopoiesis
|
|
Don
Wojchowski, Ph.D.
contact: wojchd@mmc.org
go to biographical profile
- Cytokine
receptor and transcription factor regulation of hematopoiesis,
especially erythropoiesis
|
|
Wen-Shu
Wu, Ph.D.
contact: wuw@mmc.org
go to biographical profile |
|
Jeong
Yoon, Ph.D.
contact: yoonje@mmc.org
go to biographical profile
- Molecular
mechanisms of cell fate determination, differentiation and
morphogenesis during vertebrate development
|
